United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - terazosin hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - terazosin hydrochloride - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zanza specials international ltd - terazosin hydrochloride - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zanza specials international ltd - terazosin hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - terazosin hydrochloride - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - terazosin hydrochloride - oral tablet - 10mg

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - terazosin hydrochloride dihydrate 1.187mg equivalent to 1 mg terazosin; terazosin hydrochloride dihydrate 2.347mg equivalent to 2 mg terazosin - tablet - active: terazosin hydrochloride dihydrate 1.187mg equivalent to 1 mg terazosin excipient: lactose monohydrate magnesium stearate maize starch purified talc starch active: terazosin hydrochloride dihydrate 2.347mg equivalent to 2 mg terazosin excipient: lactose monohydrate magnesium stearate maize starch quinoline yellow starch - the symptomatic and pathophysiologic treatment of benign prostatic hyperplasia (bph) when: -prostatectomy is not indicated -patient is not fit for surgery -elective surgery must be postponed (e.g., waiting list) -patient refuses surgical treatment.

New Zealand - English - Medsafe (Medicines Safety Authority)

abbott laboratories (nz) ltd - terazosin hydrochloride dihydrate 11.87mg equivalent to 10 mg terazosin - tablet - 10 mg - active: terazosin hydrochloride dihydrate 11.87mg equivalent to 10 mg terazosin excipient: indigo carmine lactose monohydrate magnesium stearate maize starch purified talc

New Zealand - English - Medsafe (Medicines Safety Authority)

abbott laboratories (nz) ltd - terazosin hydrochloride dihydrate 1.187mg equivalent to 1 mg terazosin - tablet - 1 mg - active: terazosin hydrochloride dihydrate 1.187mg equivalent to 1 mg terazosin excipient: lactose monohydrate magnesium stearate maize starch purified talc

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - terazosin hydrochloride dihydrate 2.347mg equivalent to 2 mg terazosin - tablet - 2 mg - active: terazosin hydrochloride dihydrate 2.347mg equivalent to 2 mg terazosin excipient: lactose monohydrate magnesium stearate maize starch purified talc quinoline yellow starch - the symptomatic and pathophysiologic treatment of benign prostatic hyperplasia (bph) when: -prostatectomy is not indicated -patient is not fit for surgery -elective surgery must be postponed (e.g., waiting list) -patient refuses surgical treatment.